Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Okairos

Okairos is a Basel-Stadt-based company founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese and Stefano Colloca.

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

Pharmaceuticals

Location

B2X

CEO

Riccardo Cortese

Founder

Alfredo Nicosia

Riccardo Cortese

Stefano Colloca

Antonella Folgori

Pitchbook URL

pitchbook.com/profiles.../52787-62

Number of Employees (Ranges)

1 – 10

Full Address

Elisabethenstrasse 3 Basel Switzerland

Investors

Boehringer Ingelheim Venture Fund

EQT Life Sciences

Versant Ventures

Novartis Venture Fund

Total Funding Amount (USD)

29,108,428

Latest Funding Round Date

September 14, 2010

Latest Funding Type

Other attributes

Company Operating Status

Active

Fully integrated into GlaxoSmithKline since 2013, Okairos from Basel developed T-cell based vaccines for major infectious diseases such as malaria, hepatitis C, HIV, and Ebola.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Okairos

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.